Sangamo Therapeutics SGMOQ Balance Sheet (2009-2026)

OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Sangamo Therapeutics Quarterly Balance Sheet

Periods 69 quarters
Latest Mar 2026

Sangamo Therapeutics reported total assets of $59.97M and total liabilities of $78.92M for the quarter ended Mar 2026, down 30.4% year over year. This balance sheet covers 69 quarters of results from Mar 2009 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
169.88M176.95M178.87M120.26M117.71M94.57M100.44M78.24M66.83M56.51M45.20M54.42M27.79M39.20M41.92M25.18M38.34M29.62M20.95M27.60M
Short-term InvestmentsInvestments (Current)
359.78M246.46M197.68M197.54M198.02M219.00M177.19M127.15M76.27M75.60M35.80M
Cash & Current Investments
529.65M423.41M376.55M317.80M315.72M313.57M277.63M205.39M143.10M132.11M81.00M54.42M27.79M39.20M41.92M25.18M38.34M29.62M20.95M27.60M
Receivables - NetNet Receivables
6.88M7.97M6.01M6.94M6.00M4.52M3.70M7.03M2.72M1.15M0.92M0.69M0.58M10.50M0.53M0.37M0.37M0.52M0.37M0.87M
Receivables - OtherOther Receivables
10.00M
Receivables
6.88M7.97M6.01M6.94M6.00M4.52M3.70M7.03M2.72M1.15M0.92M0.69M0.58M20.50M0.53M0.37M0.37M0.52M0.37M0.87M
Prepaid Assets
16.72M15.40M15.86M14.98M21.11M18.01M18.22M13.65M12.57M13.72M9.26M12.61M11.71M8.43M5.18M7.81M6.57M8.42M4.37M3.16M
Current Assets
554.06M447.40M398.77M340.07M343.12M336.62M300.33M227.09M159.61M147.58M94.33M68.64M40.08M58.13M51.69M37.60M49.89M44.08M35.83M37.11M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
49.59M50.82M51.52M51.60M53.50M55.99M63.53M59.88M60.72M28.44M26.87M22.02M20.62M19.15M17.89M16.88M15.73M14.79M11.04M10.32M
Long-Term Investments
49.21M95.63M88.17M82.52M47.97M36.70M29.85M35.61M39.04M
Goodwill
41.50M40.53M39.70M38.94M36.70M34.51M37.55M
Intangibles
56.30M54.93M53.76M52.68M49.53M46.44M50.73M51.56M
Goodwill & Intangibles
97.80M95.46M93.46M91.61M86.23M80.95M88.28M51.56M
Other Non-Current Assets
16.40M16.87M16.82M17.62M17.61M18.70M18.52M17.74M18.94M16.47M2.77M1.50M2.38M2.38M2.39M0.87M0.87M0.87M
Non-Current Assets
281.30M325.00M323.15M314.25M274.01M257.29M262.18M213.48M165.47M72.12M70.99M60.33M52.94M53.13M49.94M48.57M47.67M44.57M23.92M22.85M
Assets
835.36M772.40M721.92M654.31M617.13M593.91M562.51M440.57M325.07M219.70M165.32M128.96M93.01M111.26M101.64M86.17M97.56M88.64M59.75M59.97M
Liabilities
Current Liabilities
Accounts Payables
10.13M7.98M9.76M11.15M13.08M17.38M22.42M19.92M14.84M15.46M15.26M15.47M17.59M19.79M15.49M18.20M10.74M15.56M14.44M19.31M
Notes Payables
Payables
10.13M7.98M9.76M11.15M13.08M17.38M22.42M19.92M14.84M15.46M15.26M15.47M17.59M19.79M15.49M18.20M10.74M15.56M14.44M19.31M
Accumulated Expenses
15.45M14.82M11.58M14.10M14.20M14.05M16.01M15.40M18.96M14.23M23.55M18.47M15.76M11.64M8.20M9.80M13.94M9.87M9.41M15.08M
Other Accumulated Expenses
Current Deferred Revenue
93.96M90.45M85.71M80.78M78.79M71.89M51.78M9.58M6.87M1.49M0.77M7.56M7.56M7.56M7.56M0.90M0.40M
Total Current Liabilities
136.94M131.90M127.89M118.53M119.99M122.36M111.71M57.84M53.79M48.48M47.73M40.24M39.01M43.16M45.81M49.56M47.66M50.13M42.47M53.13M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
Non-Current Deferred Revenue
201.25M183.94M166.78M150.70M129.92M115.64M109.38M1.82M5.87M5.87M5.87M5.87M5.87M5.87M
Minority Interest
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax
6.96M6.80M6.65M6.51M6.12M5.74M6.27M6.37M0.02M
Operating Leases
37.33M36.12M44.06M42.82M41.53M39.71M38.99M37.70M36.37M34.98M33.52M30.82M29.10M27.73M26.25M24.88M23.46M25.42M25.09M19.33M
Other Non-Current Liabilities
7.43M7.63M1.22M1.24M1.29M1.31M1.21M1.23M1.27M1.32M1.19M1.21M1.22M1.24M0.93M0.93M0.96M0.98M0.58M0.58M
Total Non-Current Liabilities
382.48M358.75M345.36M318.55M297.56M283.45M266.34M103.73M90.17M83.46M81.25M71.06M68.10M70.89M77.93M80.33M76.99M81.42M73.43M78.34M
Total Liabilities
389.91M366.38M346.58M319.79M298.85M284.76M267.55M104.96M91.43M84.78M82.43M72.26M69.32M72.13M78.87M81.26M77.96M82.40M74.01M78.92M
Shareholder's Equity
Total Debt
Common Equity
445.46M406.02M375.34M334.52M318.28M309.15M294.96M335.61M233.64M134.92M82.89M56.70M23.69M39.13M22.77M4.91M19.60M6.24M-14.27M-18.96M
Liabilities and Shareholders Equity
835.36M772.40M721.92M654.31M617.13M593.91M562.51M440.57M325.07M219.70M165.32M128.96M93.01M111.26M101.64M86.17M97.56M88.64M59.75M59.97M
Retained Earnings
-871.08M-918.77M-956.30M-1,000.24M-1,043.42M-1,096.57M-1,148.55M-1,127.41M-1,241.92M-1,346.08M-1,406.38M-1,455.47M-1,491.59M-1,480.92M-1,504.32M-1,534.91M-1,554.90M-1,589.83M-1,627.25M-1,658.24M

Sangamo Therapeutics Balance Sheet API

Pull Sangamo Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SGMOQ&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY